Gonzalo Fernández-MirandaCEO and Co-Founder at CureAge TherapeuticsSpeaker
Agenda Sessions
Key Challenges in Non-Viral Delivery for Genetic Therapies
, 14:30View SessionPanel Discussion: Beyond AAV- Non-Viral and Novel Delivery Systems – The Future of In Vivo Delivery Systems
, 11:20View Session
